Skip to main content
Log in

Lipoic acid and diabetes II: Mode of action of lipoic acid

  • Published:
Journal of Biosciences Aims and scope Submit manuscript

Abstract

Intraperitoneal administration of lipoic acid (10 mg/100 g) does not effect changes in serum insulin levels in normal and alloxan diabetic rats, while normalising increased serum pyruvate, and impaired liver pyruvic dehydrogenase characteristic of the diabetic state. Dihydrolipoic acid has been shown to participate in activation of fatty acids with equal facility as coenzyme A. Fatty acyl dihydrolipoic acid however is sparsely thiolyzed to yield acetyl dihydrolipoic acid. Also acetyl dihydrolipoic acid does not activate pyruvate carboxylase unlike acetyl coenzyme A. The reduced thiolysis of Β-keto fatty acyl dihydrolipoic acid esters and the lack of activation of pyruvic carboxylase by acetyl dihydrolipoic acid could account for the antiketotic and antigluconeogenic effects of lipoic acid

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CoA:

Coenzyme A

DTO:

dihydrolipoic acid

DTNB:

5, 5′ dithiobis (2 nitrobenzoic acid)

DTT:

dithiothreitol

NAD:

nicotinamide adenine dinucleotide

PD:

Pyruvate dehydrogenase

PC:

pyruvate carboxylase

References

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gandhi, V.M., Wagh, S.S., Natraj, C.V. et al. Lipoic acid and diabetes II: Mode of action of lipoic acid. J Biosci 9, 117–127 (1985). https://doi.org/10.1007/BF02716838

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02716838

Keywords

Navigation